vs

Side-by-side financial comparison of PATRICK INDUSTRIES INC (PATK) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

PATRICK INDUSTRIES INC is the larger business by last-quarter revenue ($924.2M vs $622.0M, roughly 1.5× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 3.1%, a 31.3% gap on every dollar of revenue. On growth, PATRICK INDUSTRIES INC posted the faster year-over-year revenue change (9.2% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -0.5%).

Anduril Industries, Inc. is an American defense technology company specializing in the development of advanced autonomous systems.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

PATK vs RPRX — Head-to-Head

Bigger by revenue
PATK
PATK
1.5× larger
PATK
$924.2M
$622.0M
RPRX
Growing faster (revenue YoY)
PATK
PATK
+4.4% gap
PATK
9.2%
4.8%
RPRX
Higher net margin
RPRX
RPRX
31.3% more per $
RPRX
34.4%
3.1%
PATK
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-0.5%
PATK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PATK
PATK
RPRX
RPRX
Revenue
$924.2M
$622.0M
Net Profit
$29.1M
$214.2M
Gross Margin
23.0%
Operating Margin
6.2%
62.4%
Net Margin
3.1%
34.4%
Revenue YoY
9.2%
4.8%
Net Profit YoY
99.7%
2.9%
EPS (diluted)
$0.82
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PATK
PATK
RPRX
RPRX
Q4 25
$924.2M
$622.0M
Q3 25
$975.6M
$609.3M
Q2 25
$1.0B
$578.7M
Q1 25
$1.0B
$568.2M
Q4 24
$846.1M
$593.6M
Q3 24
$919.4M
$564.7M
Q2 24
$1.0B
$537.3M
Q1 24
$933.5M
$568.0M
Net Profit
PATK
PATK
RPRX
RPRX
Q4 25
$29.1M
$214.2M
Q3 25
$35.3M
$288.2M
Q2 25
$32.4M
$30.2M
Q1 25
$38.2M
$238.3M
Q4 24
$14.6M
$208.2M
Q3 24
$40.9M
$544.0M
Q2 24
$47.9M
$102.0M
Q1 24
$35.1M
$4.8M
Gross Margin
PATK
PATK
RPRX
RPRX
Q4 25
23.0%
Q3 25
22.6%
Q2 25
23.9%
Q1 25
22.8%
Q4 24
22.1%
Q3 24
23.1%
Q2 24
22.8%
Q1 24
21.9%
Operating Margin
PATK
PATK
RPRX
RPRX
Q4 25
6.2%
62.4%
Q3 25
6.8%
70.1%
Q2 25
8.3%
36.3%
Q1 25
6.5%
94.0%
Q4 24
4.7%
60.9%
Q3 24
8.1%
Q2 24
8.3%
50.2%
Q1 24
6.4%
-13.0%
Net Margin
PATK
PATK
RPRX
RPRX
Q4 25
3.1%
34.4%
Q3 25
3.6%
47.3%
Q2 25
3.1%
5.2%
Q1 25
3.8%
41.9%
Q4 24
1.7%
35.1%
Q3 24
4.4%
96.3%
Q2 24
4.7%
19.0%
Q1 24
3.8%
0.8%
EPS (diluted)
PATK
PATK
RPRX
RPRX
Q4 25
$0.82
$0.49
Q3 25
$1.01
$0.67
Q2 25
$0.96
$0.07
Q1 25
$1.11
$0.55
Q4 24
$-1.44
$0.46
Q3 24
$1.80
$1.21
Q2 24
$2.16
$0.23
Q1 24
$1.59
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PATK
PATK
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$26.4M
$618.7M
Total DebtLower is stronger
$1.3B
$9.0B
Stockholders' EquityBook value
$1.2B
$9.7B
Total Assets
$3.1B
$19.6B
Debt / EquityLower = less leverage
1.10×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PATK
PATK
RPRX
RPRX
Q4 25
$26.4M
$618.7M
Q3 25
$20.7M
$938.9M
Q2 25
$22.0M
$631.9M
Q1 25
$86.6M
$1.1B
Q4 24
$33.6M
$929.0M
Q3 24
$52.6M
$950.1M
Q2 24
$44.0M
$1.8B
Q1 24
$17.6M
$843.0M
Total Debt
PATK
PATK
RPRX
RPRX
Q4 25
$1.3B
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$1.3B
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
PATK
PATK
RPRX
RPRX
Q4 25
$1.2B
$9.7B
Q3 25
$1.2B
$9.6B
Q2 25
$1.1B
$9.5B
Q1 25
$1.1B
$9.8B
Q4 24
$1.1B
$10.3B
Q3 24
$1.1B
$10.3B
Q2 24
$1.1B
$9.8B
Q1 24
$1.1B
$9.9B
Total Assets
PATK
PATK
RPRX
RPRX
Q4 25
$3.1B
$19.6B
Q3 25
$3.1B
$19.3B
Q2 25
$3.1B
$18.3B
Q1 25
$3.2B
$17.6B
Q4 24
$3.0B
$18.2B
Q3 24
$3.1B
$18.0B
Q2 24
$3.0B
$17.7B
Q1 24
$3.0B
$16.1B
Debt / Equity
PATK
PATK
RPRX
RPRX
Q4 25
1.10×
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
1.18×
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PATK
PATK
RPRX
RPRX
Operating Cash FlowLast quarter
$130.8M
$827.1M
Free Cash FlowOCF − Capex
$112.7M
FCF MarginFCF / Revenue
12.2%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
4.50×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$246.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PATK
PATK
RPRX
RPRX
Q4 25
$130.8M
$827.1M
Q3 25
$9.1M
$702.6M
Q2 25
$149.4M
$364.0M
Q1 25
$40.1M
$596.1M
Q4 24
$102.7M
$742.5M
Q3 24
$51.5M
$703.6M
Q2 24
$137.5M
$658.2M
Q1 24
$35.2M
$664.6M
Free Cash Flow
PATK
PATK
RPRX
RPRX
Q4 25
$112.7M
Q3 25
$-17.2M
Q2 25
$131.1M
Q1 25
$19.9M
Q4 24
$77.2M
Q3 24
$33.7M
Q2 24
$120.6M
Q1 24
$19.7M
FCF Margin
PATK
PATK
RPRX
RPRX
Q4 25
12.2%
Q3 25
-1.8%
Q2 25
12.5%
Q1 25
2.0%
Q4 24
9.1%
Q3 24
3.7%
Q2 24
11.9%
Q1 24
2.1%
Capex Intensity
PATK
PATK
RPRX
RPRX
Q4 25
2.0%
Q3 25
2.7%
Q2 25
1.7%
Q1 25
2.0%
Q4 24
3.0%
Q3 24
1.9%
Q2 24
1.7%
Q1 24
1.7%
Cash Conversion
PATK
PATK
RPRX
RPRX
Q4 25
4.50×
3.86×
Q3 25
0.26×
2.44×
Q2 25
4.61×
12.06×
Q1 25
1.05×
2.50×
Q4 24
7.05×
3.57×
Q3 24
1.26×
1.29×
Q2 24
2.87×
6.45×
Q1 24
1.00×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PATK
PATK

Recreational Vehicle$276.3M30%
Distribution$222.4M24%
Marine$141.9M15%
Industrial$110.8M12%
Powersports$104.8M11%
Manufactured Housing$67.9M7%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons